TIMOTHEADOU, E., DV. SKARLOS, E. SAMANTAS, S. PAPADOPOULOS, S. MURRAY, Jana SKŘIČKOVÁ, C. CHRISTODOULOS, C. PAPAKOSTANTINOU, D. PECTASIDES, P. PAPAKOSTAS, Jana KAPLANOVÁ, E. VRETTOU, M. KARINA, P. KOSMIDIS and G. FOUNTZILAS. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients. Anticancer Research. 2007, vol. 27, 6C, p. 4481-9, 8 pp. ISSN 1802-128X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients
Name in Czech Hodnocení prognostické úlohy panelu biomarkerů u nemocných s nemalobuněčným bronchogenním karcinomem ve stádiu IB-IIIA
Authors TIMOTHEADOU, E. (300 Greece), DV. SKARLOS (300 Greece), E. SAMANTAS (300 Greece), S. PAPADOPOULOS (300 Greece), S. MURRAY (840 United States of America), Jana SKŘIČKOVÁ (203 Czech Republic, guarantor), C. CHRISTODOULOS (300 Greece), C. PAPAKOSTANTINOU (300 Greece), D. PECTASIDES (300 Greece), P. PAPAKOSTAS (300 Greece), Jana KAPLANOVÁ (203 Czech Republic), E. VRETTOU (300 Greece), M. KARINA (300 Greece), P. KOSMIDIS (300 Greece) and G. FOUNTZILAS (300 Greece).
Edition Anticancer Research, 2007, 1802-128X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Greece
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/07:00033301
Organization unit Faculty of Medicine
UT WoS 000251902000039
Keywords in English non-small cell lung cancer; biomarkers; prognosis of lung cancer
Tags biomarkers, non-small cell lung cancer, prognosis of lung cancer
Changed by Changed by: prof. MUDr. Jana Skřičková, CSc., učo 1808. Changed: 31/3/2010 13:54.
Abstract
An international study examining the prognostic strength of a panel of biomarkers used to evaluate the prognosis of patients with stage IB-IIIA non-small cell lung cancer.
Abstract (in Czech)
V rámci mezinárodní studie byly hodnoceny prognostické možnosti využití panelu biomarkerů u nemocných s nemalobuněčným bronchogenním karcinomem ve stádiu IB-IIIA.
Links
MSM 141100003, plan (intention)Name: Zevní prostředí - karcinogeneze - onkologie
Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology
PrintDisplayed: 27/8/2024 03:23